In ERα-positive tumors, ERβ reportedly suppresses cell growth, forming a heterodimer with ERα and inhibiting its tumor-promoting effect or suppressing the transcription of the c-myc, cyclin D1, or cyclin A genes. The gene discussed is CCNA2; the disease is neoplasm.